Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice

Journal of Nutrition

Volumn 135, Issue 4, 2005, Pages 729-734

  Enkhmaa, Byambaa ^a   Shiwaku, Kuninori ^a   Katsube, Takuya ^b   Kitajima, Keiko ^a   Anuurad, Erdembileg ^a   Yamasaki, Masayuki ^a   Yamane, Yosuke ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b SHIMANE INSTITUTE FOR INDUSTRIAL TECHNOLOGY   (Japan)

Author keywords

Atherosclerosis; LDL oxidation; LDLR mice; Mulberry; Quercetin 3 (6 malonylglucoside)

Indexed keywords

ALKADIENE; FLAVONOID GLYCOSIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; QUERCETIN 3 (6 MALONYLGLUCOSIDE); THEOBROMA OIL; UNCLASSIFIED DRUG;

ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENIC DIET; ATTENUATION; CHOLESTEROL DIET; CONJUGATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; MALE; MOUSE; MULBERRY; NONHUMAN; OXIDATION; PLANT LEAF; POWDER;

MORUS (PLANT); MORUS ALBA; THEOBROMA CACAO;

EID: 16244395503     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.4.729     Document Type: Article

References (46)

1. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. & Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. Witztum, J. L. & Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Investig. 88: 1785-1792.
3. Parthasarathy, S., Printz, D. J., Boyd, D., Joy, L. & Steinberg, D. (1986) Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6: 505-510.
4. Brown, M. S. & Goldstein, J. L. (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
5. Itabe, H., Takeshima, E., Iwasaki, H., Kimura, J., Yoshida, Y., Imanaka, T. & Takano, T. (1994) A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J. Biol. Chem. 269: 15274-15279.
6. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B. & Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011.
7. Knekt, P., Jarvinen, R., Reunanen, A. & Maatela, J. (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312: 478-481.
8. O'Reilly, J. D., Sanders, T. A. & Wiseman, H. (2000) Flavonoids protect against oxidative damage to LDL in vitro: use in selection of a flavonoid rich diet and relevance to LDL oxidation resistance ex vivo? Free Radic. Res. 33: 419-426.
9. Naderi, G. A., Asgary, S., Sarraf-Zadegan, N. & Shirvany, H. (2003) Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol. Cell. Biochem. 246: 193-196.
10. Day, A. J. & Williamson, G. (2001) Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma. Br. J. Nutr. 86: S105-S110.
11. Moon, J. H., Tsushida, T., Nakahara, K. & Terao, J. (2001) Identification of quercetin 3-O-β-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic. Biol. Med. 30: 1274-1285.
12. Manach, C., Morand, C., Crespy, V., Demigné, C., Texier, O., Regerat, F. & Rémésy, C. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 426: 331-336.
13. Katsube, T., Tabata, H., Ohta, Y., Yamasaki, Y., Anuurad, E., Shiwaku, K. & Yamane, Y. (2004) Screening for antioxidant activity in edible plant products: comparison of low-density lipoprotein oxidation assay, DPPH radical scavenging assay, and Folin-Ciocalteu assay. J. Agric. Food Chem. 52: 2391-2396.
14. Doi, K., Kojima, T., Makino, M., Kimura, Y. & Fujimoto, Y. (2001) Studies on the constituents of the leaves of Morus alba L. Chem. Pharm. Bull. 49: 151-153.
15. Onogi, A., Osawa, K., Yasuda, H., Sakai, A., Morita, H. & Itokawa, H. (1993) Flavonol glycosides from the leaves of Morus alba L. Nat. Med. 47: 423-425.
16. Arabbi, P. R., Genovese, M. I. & Lajolo, F. M. (2004) Flavonoids in vegetable foods commonly consumed in Brazil and estimated ingestion by the Brazilian population. J. Agric. Food Chem. 52: 1124-1131.
17. Bown, D. (1995) Encyclopedia of Herbs and Their Uses, pp. 313-314. Dorling Kindersley, London, UK.
18. Lemus, I., Garcia, R., Delvillar, E. & Knop, G. (1999) Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytother. Res. 13: 91-94.
19. Taniguchi, S., Asano, N., Tomino, F. & Miwa, I. (1998) Potentiation of glucose-induced insulin secretion by fagomine, a pseudo-sugar isolated from mulberry leaves. Horm. Metab. Res. 30: 679-683.
20. Chen, F., Nakashima, N., Kimura, I. & Kimura, M. (1995) Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice. Yakugaku Zasshi 115: 476-482.
21. Ishibashi, S., Goldstein, J. L., Brown, M. S., Herz, J. & Burns, D. K. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Investig. 93: 1885-1893.
22. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
23. Havel, R. J. & Rapaport, E. (1995) Management of primary hyperlipidemia. N. Engl. J. Med. 332: 1491-1498.
24. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. & Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
25. Rodriguez-Sureda, V., Juive, J., Llobera, M. & Peinado-Onsurbe, J. (2002) Ultracentrifugation micromethod for preparation of small experimental animal lipoproteins. Anal. Biochem. 303: 73-77.
26. Wang, J. F., Schramm, D. D., Holt, R. R., Ensunsa, J. L., Fraga, C. G., Schmitz, H. H. & Keen, C. L. (2000) A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr. 130: 2115S-2119S.
27. Lichtman, A. H., Clinton, S. K., Iiyama, K., Connelly, P. W., Libby, P. & Cybulsky, M. I. (1999) Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler. Thromb. Vasc. Biol. 19: 1938-1944.
28. Esterbauer, H., Striegl, G., Puhl, H. & Rotheneder, M. (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6: 67-75.
29. Carr, A. C., Zhu, B. Z. & Frei, B. (2000) Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 87: 349-354.
30. Afanas'ev, I. B., Dorozhko, A. I., Brodskii, A. V., Kostyuk, V. A. & Potapovitch, A. I. (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 38: 1763-1769.
31. Torel, J., Cillard, J. & Cillard, P. (1986) Antioxidant activity of flavonoids and reactivity with peroxyl radicals. Phytochemistry 25: 383-385.
32. Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Etis, A. & Aviram, M. (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17: 2744-2752.
33. Regnstrom, J., Nilsson, J., Tornvall, P., Landou, C. & Hamsten, A. (1992) Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186.
34. Fuhrman, B., Buch, S., Vaya, J., Belinky, P. A., Coleman, R., Hayek, T. & Aviram, M. (1997) Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 66: 267-275.
35. Abuja, P. M. & Albertini, R. (2001) Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306: 1-17.
36. Liu, J., Yeo, H. C., Doniger, S. J. & Ames, B. N. (1997) Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal. Biochem. 245: 161-166.
37. Hollman, P. C., van Trijp, J. M., Mengelers, M. J., de Vries, J. H. & Katan, M. B. (1997) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett. 114: 139-140.
38. Hollman, P. C., de Vries, J. H., van Leeuwen, S. D., Mengelers, M. J. & Katan, M. B. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62: 1276-1282.
39. Olthof, M. R., Hollman, P. C., Vree, T. B. & Katan, M. B. (2000) Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J. Nutr. 130: 1200-1203.
40. Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., Rhodes, M. J., Morgan, M. R. & Williamson, G. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett. 436: 71-75.
41. Day, A. J., Canada, F. J., Diaz, J. C., Kroon, P. A., Mclauchlan, R., Faulds, C. B., Plumb, G. W., Morgan, M. R. & Williamson, G. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 468: 166-170.
42. Sesink, A. L., Arts, I. C., Faassen-Peters, M. & Hollman, P. C. (2003) Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase. J. Nutr. 133: 773-776.
43. Day, A. J., Gee, J. M., DuPont, M. S., Johnson, I. T. & Williamson, G. (2003) Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem. Pharmacol. 65: 1199-1206.
44. Hollman, P. C., van Trijp, J. M., Buysman, M. N., van der Gaag, M. S., Mengelers, M. J., de Vries, J. H. & Katan, M. B. (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418: 152-156.
45. Howarth, N. C., Saltzman, E. & Roberts, S. B. (2001) Dietary fiber and weight regulation. Nutr. Rev. 59: 129-139.
46. Asano, N., Kizu, H., Oseki, K., Tomioka, E., Matsui, K., Okamoto, M. & Baba, M. (1995) N-Alkylated nitrogen-in-the-ring sugars: conformational basis of inhibition of glycosidases and HIV-1 replication. J. Med. Chem. 38: 2349-2356.